openPR Logo
Press release

Healthcare CMO Market Research Report by Service and By Geography and Forecast upto 2019

02-07-2017 01:56 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Healthcare CMO Market Research Report by Service and

Global Healthcare CMO Market: Overview

A majority of medical devices and pharmaceutical manufacturing companies around the world are gradually outsourcing their production activities to contract manufacturers to achieve cost efficiency and focus on their core competencies. Through this, the companies are aiming to capitalize on specific expertise in a given business category, which may not be available in house. The trend is thus expected to bolster opportunities for the global healthcare contract manufacturing outsourcing (CMO) market.

Obtain the Sample Containing the Upcoming Market Trends of Healthcare CMO at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2452

The report studies the global healthcare CMO market based on services and its regional segments. By service, the market is bifurcated into medical device CMO services and pharmaceutical CMO services. Of these, the pharmaceutical CMO services segment led the market with a share of 55.4% in 2012.

It presents a holistic overview of the global healthcare CMO market, covering drivers and restraints affecting its trajectory and various market segments. The report is aimed at providing better perspective about the global healthcare CMO market to the stakeholders hence it studies in detail the various factors affecting its growth across the key segments. Besides this, it identifies lucrative opportunities across key regional segments.

Global Healthcare CMO Market: Trends and Opportunities

Contract manufacturing outsourcing involves certain manufacturing activities that were previously executed by the producers. Despite being an emerging trend, the technology has taken over the healthcare industry by storm, with leading players outsourcing their manufacturing activities to contract manufacturers with an intent of reducing cost incurred on production without compromising on the product quality. The practice also helps these companies capitalize on the expertise of contract manufacturers, while concentrating on their core activities at the same time.

As per the report, the market is considerably gaining from the presence of a skilled workforce at a lower cost in emerging economies, encouraged by which healthcare companies are outsourcing certain manufacturing activities. Therefore, efforts taken by pharmaceutical and medical devices companies to restructure their manufacturing processes alongside other activities involved in the production of medical devices have strengthened the global contract manufacturing market in the healthcare industry.

Global Healthcare CMO Market: Regional Outlook

Regionally, Europe, North America, Asia Pacific, and Rest of the World constitute the key segments in the global healthcare CMO market. Of these, the dominance was enjoyed by North America as it occupied overall the largest share in 2012. However, the healthcare CMO market is expected to record highest growth in Asia Pacific at a CAGR of 17.80% between 2013 and 2019.

The implementation of favorable government regulations and amendments in intellectual property protection right are the chief drivers that will boost the Asia Pacific healthcare CMO market on a legislative front. Besides these, the market is also expected to gain from the rising uptake of novel technologies in the region. Labor cost in Asia Pacific is considerably low, which during the forecast period is likely to aid the expansion of the healthcare CMO market in the region.

Read the Current Market Status of Healthcare CMO at: http://www.transparencymarketresearch.com/healthcare-cmo-market.html

Global Healthcare CMO Market: Vendor Landscape

Piramal Healthcare, Symmetry Medical Inc., Fareva, Greatbatch Inc., Patheon Inc., Boehringer Ingelheim GmbH, Accellent Inc., Lonza Group, Catalent Pharma Solutions Inc., and DSM are some of the major companies operating in the global healthcare CMO market. Their solutions and services they offer are recognized and widely acknowledged as the most prominent ones around the world. The report therefore presents a detailed assessment of marketing strategies they adopted over the years and the impact of the same on the overall market. It includes a detailed profiles of these companies and conducts SWOT analysis to study their strengths and weaknesses and present insight into opportunities and threats that these companies may witness in the forecast period.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Healthcare CMO Market Research Report by Service and By Geography and Forecast upto 2019 here

News-ID: 430806 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for CMO

Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - …
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition Where's your place in the CMO hierarchy? Find out in the CMO industry's authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its performance
PharmSource-CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance-2018
This report is the 8th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs. Reasons to buy: This 43-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends.
CMO Scorecard Market: Outsourcing of NDA Approvals and CMO Performance
Latest industry research report on: CMO Scorecard Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Find out in the CMO industrys authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report. Request
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report. Request